Does Collagen Help With Hip Osteoarthritis?

Written by the Nuvirox Research Team

Short answer: the early data is encouraging, but it's thin. Almost all of the collagen-and-osteoarthritis research over the past two decades has focused on the knee, simply because it's the joint researchers study most in OA trials. Hip osteoarthritis has been included in far fewer studies, but a 2025 trial specifically built to include hip OA patients found a real signal — enough to say collagen is a reasonable thing to try, without overstating how established it is.

Why Does Hip Research Lag Behind Knee Research?

Partly trial design convenience, partly how OA is typically measured.

Knee osteoarthritis is easier to assess with a validated symptom questionnaire (the WOMAC index) and to image consistently, which makes it the default joint for supplement trials. Hip OA is diagnosed and measured with some of the same tools, but recruiting hip OA patients for supplement trials has historically been less common, so the evidence base is smaller by simple volume, not necessarily because hip cartilage behaves differently from knee cartilage at a biological level.

Is the Underlying Biology the Same as Knee OA?

Largely yes — both are weight-bearing joints with type II collagen-rich articular cartilage that degrades similarly.

The hip and knee are both synovial, weight-bearing joints, and the cartilage covering the joint surfaces in both is predominantly type II collagen. The same proposed mechanism for collagen peptides — providing amino acid building blocks and potentially triggering a mild anti-catabolic signal in chondrocytes — applies in principle to both joints. Researchers behind the 2025 hip/ankle trial pointed to this shared biology as the reason for testing multiple joints in one study, rather than assuming knee results would automatically generalize.

What Human Studies Actually Show

The 2025 CollaSel PRO trial (MDPI, PMC12156922) randomized 160 adults with osteoarthritis — assessed with WOMAC for knee and hip joints, and a separate ankle-specific scale — to 10g/day of type I and III hydrolyzed collagen peptides or placebo for 8 weeks, with assessments at baseline, week 1, 4, and 8. This is one of the only trials to build in a formal hip-OA outcome measure rather than knee-only.

The broader knee OA evidence, for context: a separate 2025 randomized trial (PMCID PMC12445226) found 3,000mg/day of collagen peptides over 180 days reduced WOMAC pain scores in knee OA versus placebo, with no measurable change in joint space width — meaning symptom relief didn't correspond to visible structural repair on imaging.

Honest counterweight: a systematic review referenced in the same 2025 hip/ankle trial paper noted that findings across collagen-and-OA trials remain "equivocal," and that many earlier positive studies used combination products (collagen plus chondroitin, hyaluronic acid, or vitamin C), which makes isolating collagen's individual contribution to hip-specific outcomes genuinely difficult.

What Collagen Won't Do for Hip Pain

Collagen supplementation has not been shown to reverse structural joint damage or regrow cartilage in any joint, hip included. It also won't address hip pain that isn't osteoarthritis — labral tears, femoroacetabular impingement, avascular necrosis, and referred pain from the lower back can all mimic hip OA symptoms but require completely different treatment. If hip pain is new, severe, or associated with reduced range of motion or a limp, that calls for an orthopedic evaluation and imaging before assuming it's degenerative arthritis a supplement might help.

Dose Used in the Hip-Inclusive Trial

The trial that specifically included hip OA outcomes used 10g/day of hydrolyzed collagen peptides (type I and III) for 8 weeks, with measurable improvement showing up as early as the interim assessments. That's a shorter timeline than some knee-only trials, which have run 6 months or longer, so it's reasonable to expect it may take longer than 8 weeks to fully judge results, especially at lower daily doses.

Related reading: our full evidence review of collagen and knee osteoarthritis how much collagen research supports for bone density collagen and meniscus or knee cartilage injuries our review of collagen and lower back pain

Frequently Asked Questions

Is hip osteoarthritis different from knee osteoarthritis?

Mechanically they're both degenerative changes to weight-bearing joint cartilage, but the hip is a deeper ball-and-socket joint with different biomechanics and a narrower set of surgical and nonsurgical options depending on severity.

How much collagen research exists for the hip specifically?

Far less than for the knee. As of this writing, there's essentially one dedicated randomized trial including formal hip OA outcome measures, plus the general body of joint-cartilage research that applies to both joints.

Can collagen replace a hip replacement if I need one?

No. Collagen supplementation, at best, is a symptom-management adjunct in mild-to-moderate OA. Advanced structural joint damage that's a surgical candidate needs an orthopedic surgeon's evaluation, not a supplement decision.

How long should I try collagen before deciding if it's working for hip pain?

Based on the available trial, expect at least 8 weeks before evaluating results, and know that longer knee OA trials suggest benefits may become clearer over months, not weeks.

Does collagen help prevent hip osteoarthritis, not just treat existing symptoms?

No trial has tested collagen as a preventive measure in people without existing osteoarthritis. All the available research enrolled participants who already had diagnosed joint symptoms.

What lifestyle factors have the strongest evidence for hip osteoarthritis prevention?

Maintaining a healthy body weight and avoiding repetitive high-impact joint stress have some of the most consistent supporting evidence for reducing osteoarthritis risk generally, alongside genetics and prior joint injury, which are not modifiable. Low-impact activities like swimming, cycling, and walking are generally well tolerated even for people already managing hip OA symptoms.

From Nuvirox

Why we formulated Collagen+ Complex

We built Collagen+ Complex around a simple idea: collagen support shouldn't come from a single source. Joint cartilage relies on type II collagen support, but tendons and ligaments around the joint lean on type I — which is part of why we didn't build this around a single collagen source. The formula blends peptides from multiple collagen types to reflect the variety naturally found throughout the body's connective tissue, rather than relying on one source alone. We're currently updating the formula, so exact composition details will be posted on the product page ahead of the next batch.

Every order is backed by our 60-day money-back guarantee — long enough to actually evaluate it the way the research above suggests you should.

Learn more about Collagen+ Complex →

The Bottom Line

Hip osteoarthritis has a smaller collagen evidence base than the knee, but the trial that does exist found real symptom improvement over 8 weeks. It's a reasonable thing to try alongside standard hip OA management — weight management, physical therapy, and appropriate medical care — but it isn't established enough to be treated as a primary or proven treatment on its own, and it's not a substitute for ruling out other causes of hip pain first.

References

1. Demir-Dora D, et al. Evaluation of the Efficacy and Safety of CollaSel PRO Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis. J Clin Med. 2025. PMCID: PMC12156922.
2. Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. PMC. 2025. PMCID: PMC12445226.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.